News
Rapid Development and Industrialization of a COVID-19 Viral Vector Vaccine Manufacturing Process
The year 2020 will go down in history books as a year that changed the world and helped drug manufacturing to evolve. When the COVID-19 pandemic began at the start of the year, vaccine production was less of an...
News
Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia
Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on "Non-clinical and clinical pathways for rapid vaccine development in Australia", in a webinar hosted by Endpoints...
News
Nucleome Unveils South Asia’s Largest and Most Advanced Genomics Research Centre; To Sequence 5000 COVID Genomes
In a move that will mark the beginning of a new era in India’s genomics capability, Nucleome Informatics today unveiled South Asia’s largest and most advanced genomics facility, NKC Centre for Genomics Research in Hyderabad. The laboratory will carry...
News
BOMI Group joins the Veratrak-led Integrated Warehouse Project aimed at connecting HLS companies with their LSP partners
UK-based software provider to the life science industry, Veratrak, has announced a collaboration with BOMI Group.
BOMI Group operates in the field of logistics and management of advanced technology healthcare products, offering clients a wide range of tailored services: warehousing,...
News
DFE Pharma Proudly Supports COVID-19 Vaccination Supply in Pakistan
DFE Pharma, a global leader in pharmaceutical excipient solutions, is proud to announce its collaboration with AJM Pharma as a key supplier with BioHale® Sucrose to support COVID-19 vaccine supply challenges in Pakistan.
In April, vaccine supplies were running out...
Drug Research
Shoreline Launches into Era of Cell Therapy with $4 Billion in Partnerships
Shoreline Biosciences, an immunotherapy company formed in 2020 during the early days of the COVID-19 pandemic, was propelled into the proverbial catbird’s seat this summer with two mega-deals, and now plans to double its employee base from 50 to...
Drug Research
Abveris and Abilita Bio Announce a Discovery Collaboration to Develop Therapeutics for Challenging Membrane Protein Targets
Abveris, Inc., and Abilita Bio, Inc., both privately held biotechnology companies, announce a joint research collaboration that will leverage the synergies between their platforms to enable the discovery of novel antibodies targeting key GPCRs within the tumor immune microenvironment.
The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















